White matter hyperintensities, cognitive impairment and dementia: an update

ND Prins, P Scheltens - Nature Reviews Neurology, 2015 - nature.com
White matter hyperintensities (WMHs) in the brain are the consequence of cerebral small
vessel disease, and can easily be detected on MRI. Over the past three decades, research …

Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia

V Di Lazzaro, R Bella, A Benussi, M Bologna… - Clinical …, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …

Pathology and pathogenesis of vascular cognitive impairment—a critical update

KA Jellinger - Frontiers in aging neuroscience, 2013 - frontiersin.org
Vascular cognitive impairment (VCI)[vascular cognitive disorder (VCD), vascular dementia]
describes a continuum of cognitive disorders ranging from mild cognitive impairment (MCI) …

Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses

AMJ MacLullich, KJ Ferguson, T Miller… - Journal of …, 2008 - Elsevier
Delirium is a common and serious acute neuropsychiatric syndrome with core features of
inattention and cognitive impairment, and associated features including changes in arousal …

Vascular cognitive impairment: current concepts and clinical developments

P Moorhouse, K Rockwood - The Lancet Neurology, 2008 - thelancet.com
Vascular cognitive impairment (VCI) comprises a range of cognitive disorders related to
cerebral vessel disease and has generally replaced the term multi-infarct dementia. Despite …

White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study

D Medina, L deToledo-Morrell, F Urresta… - Neurobiology of …, 2006 - Elsevier
Diffusion tensor imaging (DTI) can detect, in vivo, the directionality of molecular diffusion and
estimate the microstructural integrity of white matter (WM) tracts. In this study, we examined …

Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial

S Black, GC Román, DS Geldmacher, S Salloway… - Stroke, 2003 - Am Heart Assoc
Background and Purpose—Clinical observations suggest that patients with vascular
dementia (VaD) may benefit from treatment with cholinesterase inhibitors. This study …

Emerging therapies for vascular dementia and vascular cognitive impairment

T Erkinjuntti, G Roman, S Gauthier, H Feldman… - Stroke, 2004 - Am Heart Assoc
Background—Cerebrovascular disease (CVD) and ischemic brain injury secondary to
cardiovascular disease are common causes of dementia and cognitive decline in the …

Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system

NM Kanaan, GF Pigino, ST Brady, O Lazarov… - Experimental …, 2013 - Elsevier
Alzheimer's disease (AD) is characterized by progressive, age-dependent degeneration of
neurons in the central nervous system. A large body of evidence indicates that neurons …

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL

M Dichgans, HS Markus, S Salloway… - The Lancet …, 2008 - thelancet.com
Background Cholinergic deficits might contribute to vascular cognitive impairment. Trials of
cholinesterase inhibitors in patients with vascular dementia are difficult because of …